Cellular senescence of tumour cells through p53 activation has also been shown to be associated with increasing tumour immunogenicity through the release of pro-inflammatory cytokines and the recruitment of innate immune cells, such as macrophages and natural killer cells [100,101,102]. Here, TP53 is linked to neoplasm.